Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dave R Praharaj
Real-Time Nanoscale Proteomic Analysis of the Novel Multi-Kinase Pathway Inhibitor Rigosertib to Measure the Response to Treatment of Cancer
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
Related publications
Quantitative- And Phospho-Proteomic Analysis of the Yeast Response to the Tyrosine Kinase Inhibitor Imatinib to Pharmacoproteomics-Guided Drug Line Extension
OMICS A Journal of Integrative Biology
Genetics
Molecular Biology
Biochemistry
Molecular Medicine
Medicine
Biotechnology
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers
PLoS ONE
Multidisciplinary
Transcriptomic and Functional Pathway Analysis of Human Cervical Carcinoma Cancer Cells Response to Microtubule Inhibitor
Journal of Cancer
Oncology
A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3
Haematologica
Hematology
Mathematical Modelling of the MAP Kinase Pathway Using Proteomic Datasets
PLoS ONE
Multidisciplinary
Proteomic Analysis Implicates Dominant Alterations of RNA Metabolism and the Proteasome Pathway in the Cellular Response to Carbon-Ion Irradiation
PLoS ONE
Multidisciplinary
Proteomic Analysis of Plasmodium Falciparum Response to Isocryptolepine Derivative
PLoS ONE
Multidisciplinary
Stimulatory Effects of the Multi-Kinase Inhibitor Sorafenib on Human Bladder Cancer Cells
British Journal of Pharmacology
Pharmacology
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
PLoS ONE
Multidisciplinary
